Not Available in Canada
- Easily done at home in minutes
- DNAffirm technology ensures 99.8% accuracy
- Exclusive dual affirm primary and confirmatory test
- Provides the earliest diagnosis of vulnerability to prostate cancer
- Results in minutes that clearly indicate your status
- Early detection is critical in the treatment of prostate cancer
The Viaguard P.S.A Presymptomatic Prostate Test is the most accurate guide to early the detection of prostate cancer, because in the incipient stages there are no signs or symptoms.
PSA (Prostate specific antigen) is a glycoprotein produced by the cells of the prostate gland and absorbed into the blood stream. An increase level of PSA is associated with localized and metastatic prostate cancer.
The prostate gland is about the size of a large walnut and is located close to the rectum just below the bladder at the base of the penis. The prostate surrounds the urethra, the tube that carries urine and semen through the penis.
PSA at normal levels has an important function. It enables liquifaction of semen allowing for sperm mobility and also alters cervical mucous to facilitate sperm entry.
PSA as produced by the prostate is absorbed into the blood stream and becomes bound to two proteins. ACT (Anti-chimotrypsin) and aMG (alpha macroglobulin). The Viaguard PSA test measures the level of free and bound PSA in the blood.
A level up to 4 ng/ml is the normal range. As the level of PSA escalates the probability of prostate cancer increases accordingly.
The PSA test utilizes Viaguard advanced polymer technology. A thin film of antigen immobilizes PSA antibodies in your blood and forms a complex. If the detected level is greater than 5 ng/ml of PSA a colourmetric reaction using embedded dye particles results in the formation of a pink band in the t-region of the cassette. A positive test means medical consultation is indicated.
Signs and Symptoms of Prostate Cancer
- Need to urinate often, especially at night
- Difficulty in starting or stopping urine flow
- Burning or pain during urination
- Blood in the urine or semen
- Painful ejaculation
An overview of prostate cancer:
The PSA level is roughly indicative of the amount of cancer that is present. A PSA level exceeding 10 is sufficiently high to negate certain treatment options. A second factor in evaluating prostate cancer GLESON Score which is determined by a pathological examination of cells and relates to how aggressive the cancer appears. There are two components of this score but a total exceeding 6 is cause for concern.
The status of prostate cancer is described in four stages:
The higher the number the more severe the cancer and the greater penetration into other tissues.
WITH EARLY DETECTION PROSTATE CANCER IS NOT ONLY TREATABLE BUT CURABLE.